The Scotts Miracle-Gro Company (NYSE:SMG – Get Free Report)’s stock price hit a new 52-week high during trading on Monday after Stifel Nicolaus raised their price target on the stock from $75.00 to $81.00. Stifel Nicolaus currently has a hold rating on the stock. Scotts Miracle-Gro traded as high as $91.60 and last traded at $90.74, with a volume of 68462 shares changing hands. The stock had previously closed at $89.66.
A number of other equities research analysts also recently issued reports on SMG. Wells Fargo & Company boosted their target price on shares of Scotts Miracle-Gro from $75.00 to $85.00 and gave the company an “overweight” rating in a report on Thursday, August 1st. Truist Financial upped their price objective on Scotts Miracle-Gro from $65.00 to $90.00 and gave the stock a “hold” rating in a report on Wednesday, October 16th. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Scotts Miracle-Gro currently has a consensus rating of “Hold” and a consensus price target of $85.25.
Read Our Latest Stock Report on Scotts Miracle-Gro
Insider Activity at Scotts Miracle-Gro
Hedge Funds Weigh In On Scotts Miracle-Gro
Large investors have recently modified their holdings of the stock. Price T Rowe Associates Inc. MD raised its stake in Scotts Miracle-Gro by 24.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,726,338 shares of the basic materials company’s stock valued at $203,359,000 after buying an additional 542,406 shares in the last quarter. AQR Capital Management LLC raised its position in shares of Scotts Miracle-Gro by 194.2% during the 2nd quarter. AQR Capital Management LLC now owns 761,063 shares of the basic materials company’s stock valued at $49,515,000 after acquiring an additional 502,353 shares in the last quarter. Earnest Partners LLC lifted its stake in Scotts Miracle-Gro by 18.2% during the first quarter. Earnest Partners LLC now owns 3,113,153 shares of the basic materials company’s stock worth $232,210,000 after purchasing an additional 479,315 shares during the last quarter. Interval Partners LP boosted its holdings in Scotts Miracle-Gro by 3,581.1% in the first quarter. Interval Partners LP now owns 478,546 shares of the basic materials company’s stock worth $35,695,000 after purchasing an additional 465,546 shares during the period. Finally, International Assets Investment Management LLC increased its stake in Scotts Miracle-Gro by 8,330.2% during the third quarter. International Assets Investment Management LLC now owns 281,485 shares of the basic materials company’s stock valued at $24,405,000 after purchasing an additional 278,146 shares during the last quarter. Institutional investors own 74.07% of the company’s stock.
Scotts Miracle-Gro Price Performance
The stock’s fifty day simple moving average is $79.90 and its two-hundred day simple moving average is $72.02. The company has a market capitalization of $5.20 billion, a price-to-earnings ratio of -19.36 and a beta of 1.76.
Scotts Miracle-Gro Company Profile
The Scotts Miracle-Gro Company, together with its subsidiaries, manufactures, markets, and sells products for lawn, garden care, and indoor and hydroponic gardening in the United States and internationally. It operates through three segments: U.S. Consumer, Hawthorne, and Other. The company provides lawn care products, comprising lawn fertilizers, grass seed products, spreaders, and other durable products, as well as lawn-related weed, pest, and disease control products; and gardening and landscape products, which include water-soluble and continuous-release plant foods, potting mixes, garden soils, mulches and ground cover products, plant-related pest and disease control products, organic garden products, and live goods and seeding solutions.
See Also
- Five stocks we like better than Scotts Miracle-Gro
- What Are Trending Stocks? Trending Stocks Explained
- Intel: Is Now the Time to Be Brave?Â
- 3 Healthcare Dividend Stocks to Buy
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Following Congress Stock Trades
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Scotts Miracle-Gro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scotts Miracle-Gro and related companies with MarketBeat.com's FREE daily email newsletter.